TrialShare is a transformative approach to data-sharing that enables clinical trial transparency. TrialShare provides clinical trial investigators the unprecedented ability to access de-identified study data, review published analysis methods, and perform real-time, interactive graphical analyses in collaboration with other researchers. Immune Tolerance Network (ITN) TrialShare shares information about ITN's clinical studies and specimen bio-repository. Data and analysis code underlying ITN-published manuscripts are publicly available with the goal of promoting transparency, reproducibility, and scientific collaboration.
More information about this resource is available at TrialShare
Main Areas of Focus
- To advance the clinical application of immune tolerance therapies and biomarker development
- To perform high quality clinical trials integrated with mechanism-based research with a focus on allergy, transplantation, and autoimmune disease
Tools
- Data and analysis code underlying ITN-published manuscripts
- Biological specimens from well-phenotyped study participants
- Trialshare’s tools allow researchers to:
- Find relevant datasets
- Filter and sort data
- Create participant groups
- Visualize data through graphs
- Download datasets
- Search the specimen repository and download reports on available specimens based on custom criteria
Collaboration Opportunities
- Data sharing
- Sample sharing
- Specimen bio-repository